Merck Shares Priorities and Strategy for Environmental, Social, and Governance
Merck & Co., Inc.
Today at 10:00 a.m. EST, Merck, also known as MSD outside of the United States and Canada, will host a virtual investor event where members of its senior management team will talk about Merck's environmental, social, and governance (ESG) initiatives.
The event will outline the company’s long-term ESG strategy focused on four priority areas – Access to Health, Employees, Environmental Sustainability and Ethics & Values – and how this strategy is fundamental to Merck’s long-term business value and success.
Merck’s ESG strategy and the company’s stated ESG goals regarding health equity and access, diversity and carbon neutrality are aligned to the United Nations 2030 Sustainable Development Goals (UN SDGs). Senior management presentations will discuss the company’s ESG strategy and performance, and how ESG is at the core of Merck’s purpose to save and improve lives.
Investors, analysts, members of the media and the general public are invited to listen to the webcast of the presentation at Merck & Co., Inc. ESG Event - Merck.com. There will be a Q&A panel session with the senior management team following the prepared remarks.
About Merck: For over 130 years, Merck, known as MSD outside the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world.
For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.
Source: Merck news
